کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1345390 1500337 2015 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
From racemic epichlorohydrin to a single enantiomer of the drug timolol maleate
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی معدنی
پیش نمایش صفحه اول مقاله
From racemic epichlorohydrin to a single enantiomer of the drug timolol maleate
چکیده انگلیسی

The synthesis for a single enantiomer timolol maleate based on an initial Jacobsen hydrolytic kinetic resolution of racemic epichlorohydrin and on the stereochemistry of the subsequent chemical transformations has been proposed. The feature of this synthesis is that both products of the kinetic resolution, (R)-epichlorohydrin (R)-4 and (S)-3-chloropropane-1,2-diol (S)-5, have been utilized in the synthesis of the target, (S)-timolol. The mirror stereochemical results can be obtained with the use of (R,R)-salen Co(III) catalyst instead of (S,S)-salen Co(III).

Figure optionsDownload as PowerPoint slide

(2R)-1-Chloro-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-olC9H14ClN3O3SEe = 96% (ee from HPLC)[α]D25 = +6.7 (c 0.9, CHCl3)Initial source of chirality: (R)-EpichlorohydrinAbsolute configuration: (R)

(S)-1-(tert-Butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanolC13H24N4O3SEe = 99% (ee from HPLC)[α]D25 = −4.7 (c 1, CHCl3); [α]43625 = −6.4 (c 1, CHCl3)Initial source of chirality: 4-{4-[(2S)-Oxiran-2-ylmethoxy]-1,2,5-thiadiazol-3-yl}morpholineAbsolute configuration: (S)

(S)-1-(tert-Butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol hemimaleate saltC17H28N4O7SEe = 99% (ee from HPLC)[α]D25 = −7.0 (c 4, 1 M aq HCl); [α]43625 = −12.7 (c 4, 1 M aq HCl)Initial source of chirality: 4-{4-[(2S)-Oxiran-2-ylmethoxy]-1,2,5-thiadiazol-3-yl}morpholineAbsolute configuration: (S)

4-{4-[(2S)-Oxiran-2-ylmethoxy]-1,2,5-thiadiazol-3-yl}morpholineC9H13N3O3SEe = 99% (ee from HPLC)[α]D25 = +28.9 (c 1.0, CHCl3)Initial source of chirality: (S)-3-(4-Morpholin-4-yl-1,2,5-thiadiazol-3-yloxy)-propane-1,2-diol or (R)-epichlorohydrinAbsolute configuration: (S)

(S)-3-(4-Morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propane-1,2-diolC9H15N3O4SEe = 99.8% (ee from HPLC)[α]D20 = +17.5 (c 1, EtOH)Initial source of chirality: (S)-3-Chloropropane-1,2-diolAbsolute configuration: (S)

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Tetrahedron: Asymmetry - Volume 26, Issues 15–16, 31 August 2015, Pages 797–801
نویسندگان
, , , , ,